2025
SJR Q1
JCR Q1 · 91,2
1 eşleşen makale
SCIE
Dergi ayrıntısı
Nature Reviews Drug Discovery
- Yayıncı
- Nature Research
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
1474177614741784
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 32,577
- Quartile Q1
- H-Index 428
- Atıf/yayın 15,31
- Doküman (3y) 716
- Atıf (3y) 12.533
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 91,2
- 5Y JIF 131,3
- JCI 10,92
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Drug Discovery Q1
- Medicine (miscellaneous) Q1
- Pharmacology Q1
Alanlar
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Biotechnology & Applied Microbiology | Pharmacology & Pharmacy
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 32,577 | 91,2 | 131,3 | 10,92 | Q1 | 428 |
| 2024 | Q1 | Q1 | 30,506 | 101,8 | 129,8 | 13,97 | Q1 | 412 |
| 2023 | Q1 | Q1 | 22,399 | 122,8 | 115 | 13,36 | Q1 | 412 |
| 2022 | Q1 | Q1 | 19,423 | 120,1 | 111,5 | 12,45 | Q1 | 412 |
| 2021 | Q1 | Q1 | 11,296 | 112,3 | 98,7 | 9,76 | Q1 | 412 |
| 2020 | Q1 | Q1 | 9,921 | 84,7 | 80,6 | 10,86 | Q1 | 412 |
| 2019 | Q1 | Q1 | 7,018 | 64,8 | 60,8 | 9,58 | Q1 | 412 |
| 2018 | — | Q1 | — | 57,6 | 58,9 | 10,22 | Q1 | — |
| 2017 | Q1 | Q1 | 10,106 | 50,2 | 54,5 | 9,61 | Q1 | 412 |
| 2016 | Q1 | Q1 | 12,597 | 57 | 49,6 | — | — | 412 |
| 2015 | Q1 | Q1 | 12,019 | 47,1 | 43 | — | — | 412 |
| 2014 | Q1 | Q1 | 9,338 | 41,9 | 37,8 | — | — | 412 |
| 2013 | Q1 | Q1 | 7,283 | 37,2 | 35,4 | — | — | 412 |
| 2012 | Q1 | Q1 | 6,54 | 33,1 | 33,2 | — | — | 412 |
| 2011 | Q1 | Q1 | 6,281 | 29 | 32,1 | — | — | 412 |
| 2010 | Q1 | Q1 | 6,569 | 28,7 | 30,9 | — | — | 412 |
| 2009 | — | Q1 | — | 29,1 | 28 | — | — | — |
| 2008 | — | Q1 | — | 28,7 | 24,9 | — | — | — |
| 2007 | — | Q1 | — | 23,3 | 22,5 | — | — | — |
| 2006 | — | Q1 | — | 21 | — | — | — | — |
| 2005 | — | Q1 | — | 18,8 | — | — | — | — |
| 2004 | — | Q1 | — | 19,6 | — | — | — | — |
| 2003 | — | Q1 | — | 17,7 | — | — | — | — |
| 2002 | — | — | — | — | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 1/180 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 1/356 |
| 2024 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 1/177 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 1/352 |
| 2023 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 1/174 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 1/354 |
| 2022 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 1/158 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 1/278 |
| 2021 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 1/159 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 1/279 |
| 2020 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 1/159 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 1/276 |
| 2019 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 1/156 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 1/271 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 1/162 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 1/267 |
| 2017 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 1/161 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 1/261 |
| 2016 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 1/160 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 1/257 |
| 2015 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 1/161 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 1/255 |
| 2014 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 1/163 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 1/255 |
| 2013 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 2/165 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 1/256 |
| 2012 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 1/160 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 1/261 |
| 2011 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 1/158 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 1/261 |
| 2010 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 2/160 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 1/252 |
| 2009 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 2/152 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 1/237 |
| 2008 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 1/144 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 1/219 |
| 2007 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 1/138 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 1/205 |
| 2006 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 3/140 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 2/199 |
| 2005 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 2/139 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 2/193 |
| 2004 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 2/133 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 3/187 |
| 2003 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 1/132 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 3/185 |
| 2002 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | — | — | — |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | — | — | — |